<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39459880</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Identification of a Novel Antiviral Lectin against SARS-CoV-2 Omicron Variant from Shiitake-Mushroom-Derived Vesicle-like Nanoparticles.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1546</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16101546</ELocationID><Abstract><AbstractText>Lectins are a class of carbohydrate-binding proteins that may have antiviral activity by binding to the glycans on the virion surface to interfere with viral entry. We have identified a novel lectin (named Shictin) from Shiitake mushroom (<i>Lentinula edodes</i>)-derived vesicle-like nanoparticles (VLNs, or exosomes) that exhibits strong activity against the SARS-CoV-2 Omicron variant with an IC<sub>50</sub> value of 87 nM. Shictin contains 298 amino acids and consists of two unique domains (N-terminal and C-terminal domain). The N-terminal domain is the carbohydrate-binding domain (CBD) that is homologous with CBDs of other lectins, suggesting that Shictin inhibits SARS-CoV-2 infection by binding to the glycans on the virion surface to prevent viral entry. This finding demonstrates that exosomes of vegetables are a valuable source for the identification of antiviral lectins. Therefore, it is believed that lectins from vegetable VLNs have potential as antiviral therapeutic agents.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wiggins</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8574-5073</Identifier><AffiliationInfo><Affiliation>Nebraska Center for Virology, University of Nebraska-Lincoln, Morrison Center 143, 4240 Fair Street, Lincoln, NE 68583, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karim</LastName><ForeName>Shazeed-Ul</ForeName><Initials>SU</Initials><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, School of Biological, Environmental, and Earth Sciences, University of Southern Mississippi, Hattiesburg, MS 39406, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Baolong</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Nutrition and Health Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xingzhi</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-2784-4575</Identifier><AffiliationInfo><Affiliation>Department of Nutrition and Health Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>You</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biotechnology, University of Nebraska-Lincoln, Lincoln, NE 68583, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Fengwei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, School of Biological, Environmental, and Earth Sciences, University of Southern Mississippi, Hattiesburg, MS 39406, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jiujiu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Nutrition and Health Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Shi-Hua</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0002-5656-5698</Identifier><AffiliationInfo><Affiliation>Nebraska Center for Virology, University of Nebraska-Lincoln, Morrison Center 143, 4240 Fair Street, Lincoln, NE 68583, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>5T32NS105594</GrantID><Agency>NIH T-32 fellowship grant</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037102">Lectins</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="Y">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D037102" MajorTopicYN="Y">Lectins</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053758" MajorTopicYN="Y">Nanoparticles</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020942" MajorTopicYN="Y">Shiitake Mushrooms</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053586" MajorTopicYN="N">Virus Internalization</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055354" MajorTopicYN="N">Exosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="N">COVID-19 Drug Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Shictin</Keyword><Keyword MajorTopicYN="N">exosomes</Keyword><Keyword MajorTopicYN="N">extracellular vesicles (EVs)</Keyword><Keyword MajorTopicYN="N">lectin</Keyword><Keyword MajorTopicYN="N">shiitake mushroom</Keyword><Keyword MajorTopicYN="N">vegetable</Keyword><Keyword MajorTopicYN="N">vesicle-like nanoparticles (VLNs)</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39459880</ArticleId><ArticleId IdType="pmc">PMC11512411</ArticleId><ArticleId IdType="doi">10.3390/v16101546</ArticleId><ArticleId IdType="pii">v16101546</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dilcher M., Werno A., Jennings L.C. SARS-CoV-2: A Novel Deadly Virus in a Globalised World. N. Z. Med. J. 2020;133:6–11.</Citation><ArticleIdList><ArticleId IdType="pubmed">32078595</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E.C. The Emergence and Evolution of SARS-CoV-2. Annu. Rev. Virol. 2024;11:24–42. doi: 10.1146/annurev-virology-093022-013037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-093022-013037</ArticleId><ArticleId IdType="pubmed">38631919</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W., Tian J.-H., Pei Y.-Y., et al. A New Coronavirus Associated with Human Respiratory Disease in China. Nature. 2020;579:265–269. doi: 10.1038/s41586-020-2008-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2008-3</ArticleId><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronaviridae Study Group of the International Committee on Taxonomy of Viruses The Species Severe Acute Respiratory Syndrome-Related Coronavirus: Classifying 2019-nCoV and Naming It SARS-CoV-2. Nat. Microbiol. 2020;5:536–544. doi: 10.1038/s41564-020-0695-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-0695-z</ArticleId><ArticleId IdType="pmc">PMC7095448</ArticleId><ArticleId IdType="pubmed">32123347</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi W., Cai Y., Zhu H., Peng H., Voyer J., Rits-Volloch S., Cao H., Mayer M.L., Song K., Xu C., et al. Cryo-EM Structure of SARS-CoV-2 Postfusion Spike in Membrane. Nature. 2023;619:403–409. doi: 10.1038/s41586-023-06273-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06273-4</ArticleId><ArticleId IdType="pubmed">37285872</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Xiao T., Cai Y., Chen B. Structure of SARS-CoV-2 Spike Protein. Curr. Opin. Virol. 2021;50:173–182. doi: 10.1016/j.coviro.2021.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8423807</ArticleId><ArticleId IdType="pubmed">34534731</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe Y., Allen J.D., Wrapp D., McLellan J.S., Crispin M. Site-Specific Glycan Analysis of the SARS-CoV-2 Spike. Science. 2020;369:330–333. doi: 10.1126/science.abb9983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb9983</ArticleId><ArticleId IdType="pmc">PMC7199903</ArticleId><ArticleId IdType="pubmed">32366695</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Baudys J., Osman S.H., Barr J.R. Analysis of the N-Glycosylation Profiles of the Spike Proteins from the Alpha, Beta, Gamma, and Delta Variants of SARS-CoV-2. Anal. Bioanal. Chem. 2023;415:4779–4793. doi: 10.1007/s00216-023-04771-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00216-023-04771-y</ArticleId><ArticleId IdType="pmc">PMC10352417</ArticleId><ArticleId IdType="pubmed">37354227</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Y., Qin S., Dai L., Tian Z. The Glycosylation in SARS-CoV-2 and Its Receptor ACE2. Sig. Transduct. Target. Ther. 2021;6:396. doi: 10.1038/s41392-021-00809-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00809-8</ArticleId><ArticleId IdType="pmc">PMC8591162</ArticleId><ArticleId IdType="pubmed">34782609</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez C., Félix C., Lemos M.F.L. The Antiviral Potential of Algal Lectins. Mar. Drugs. 2023;21:515. doi: 10.3390/md21100515.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/md21100515</ArticleId><ArticleId IdType="pmc">PMC10608189</ArticleId><ArticleId IdType="pubmed">37888450</ArticleId></ArticleIdList></Reference><Reference><Citation>Barre A., Bourne Y., Van Damme E.J.M., Rougé P. Overview of the Structure–Function Relationships of Mannose-Specific Lectins from Plants, Algae and Fungi. Int. J. Mol. Sci. 2019;20:254. doi: 10.3390/ijms20020254.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20020254</ArticleId><ArticleId IdType="pmc">PMC6359319</ArticleId><ArticleId IdType="pubmed">30634645</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R.S., Walia A.K., Khattar J.S., Singh D.P., Kennedy J.F. Cyanobacterial Lectins Characteristics and Their Role as Antiviral Agents. Int. J. Biol. Macromol. 2017;102:475–496. doi: 10.1016/j.ijbiomac.2017.04.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2017.04.041</ArticleId><ArticleId IdType="pubmed">28437766</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho L.C.B.B., Silva P.M.D.S., de Menezes Lima V.L., Pontual E.V., Paiva P.M.G., Napoleão T.H., Correia M.T.D.S. Lectins, Interconnecting Proteins with Biotechnological/Pharmacological and Therapeutic Applications. Evid. Based Complement. Alternat. Med. 2017;2017:1594074. doi: 10.1155/2017/1594074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/1594074</ArticleId><ArticleId IdType="pmc">PMC5359455</ArticleId><ArticleId IdType="pubmed">28367220</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan X., Liu W., Ng T.B. Development and Applications of Lectins as Biological Tools in Biomedical Research. Med. Res. Rev. 2016;36:221–247. doi: 10.1002/med.21363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21363</ArticleId><ArticleId IdType="pubmed">26290041</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R.S., Thakur S.R., Bansal P. Algal Lectins as Promising Biomolecules for Biomedical Research. Crit. Rev. Microbiol. 2015;41:77–88. doi: 10.3109/1040841X.2013.798780.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/1040841X.2013.798780</ArticleId><ArticleId IdType="pmc">PMC7113906</ArticleId><ArticleId IdType="pubmed">23855360</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Yadav K., Yadav A., Ahmad R., Srivastava A., Kumar D., Khan M.A., Dwivedi U.N. Mannose-Specific Plant and Microbial Lectins as Antiviral Agents: A Review. Glycoconj. J. 2024;41:1–33. doi: 10.1007/s10719-023-10142-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10719-023-10142-7</ArticleId><ArticleId IdType="pubmed">38244136</ArticleId></ArticleIdList></Reference><Reference><Citation>Naik S., Kumar S. Lectins from Plants and Algae Act as Anti-Viral against HIV, Influenza and Coronaviruses. Mol. Biol. Rep. 2022;49:12239–12246. doi: 10.1007/s11033-022-07854-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-022-07854-8</ArticleId><ArticleId IdType="pmc">PMC9510388</ArticleId><ArticleId IdType="pubmed">36138301</ArticleId></ArticleIdList></Reference><Reference><Citation>Akkouh O., Ng T.B., Singh S.S., Yin C., Dan X., Chan Y.S., Pan W., Cheung R.C.F. Lectins with Anti-HIV Activity: A Review. Molecules. 2015;20:648–668. doi: 10.3390/molecules20010648.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules20010648</ArticleId><ArticleId IdType="pmc">PMC6272367</ArticleId><ArticleId IdType="pubmed">25569520</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolmstedt A.J., O’Keefe B.R., Shenoy S.R., McMahon J.B., Boyd M.R. Cyanovirin-N Defines a New Class of Antiviral Agent Targeting N-Linked, High-Mannose Glycans in an Oligosaccharide-Specific Manner. Mol. Pharmacol. 2001;59:949–954. doi: 10.1124/mol.59.5.949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.59.5.949</ArticleId><ArticleId IdType="pubmed">11306674</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd M.R., Gustafson K.R., McMahon J.B., Shoemaker R.H., O’Keefe B.R., Mori T., Gulakowski R.J., Wu L., Rivera M.I., Laurencot C.M., et al. Discovery of Cyanovirin-N, a Novel Human Immunodeficiency Virus-Inactivating Protein That Binds Viral Surface Envelope Glycoprotein Gp120: Potential Applications to Microbicide Development. Antimicrob. Agents Chemother. 1997;41:1521–1530. doi: 10.1128/AAC.41.7.1521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.41.7.1521</ArticleId><ArticleId IdType="pmc">PMC163952</ArticleId><ArticleId IdType="pubmed">9210678</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C. Griffithsin, a Highly Potent Broad-Spectrum Antiviral Lectin from Red Algae: From Discovery to Clinical Application. Mar. Drugs. 2019;17:567. doi: 10.3390/md17100567.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/md17100567</ArticleId><ArticleId IdType="pmc">PMC6835697</ArticleId><ArticleId IdType="pubmed">31590428</ArticleId></ArticleIdList></Reference><Reference><Citation>Lusvarghi S., Bewley C.A. Griffithsin: An Antiviral Lectin with Outstanding Therapeutic Potential. Viruses. 2016;8:296. doi: 10.3390/v8100296.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v8100296</ArticleId><ArticleId IdType="pmc">PMC5086628</ArticleId><ArticleId IdType="pubmed">27783038</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrison A.R., Giomarelli B.G., Lear-Rooney C.M., Saucedo C.J., Yellayi S., Krumpe L.R.H., Rose M., Paragas J., Bray M., Olinger G.G., et al. The Cyanobacterial Lectin Scytovirin Displays Potent in Vitro and in Vivo Activity against Zaire Ebola Virus. Antiviral Res. 2014;112:1–7. doi: 10.1016/j.antiviral.2014.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2014.09.012</ArticleId><ArticleId IdType="pmc">PMC4258435</ArticleId><ArticleId IdType="pubmed">25265598</ArticleId></ArticleIdList></Reference><Reference><Citation>McFeeters R.L., Xiong C., O’Keefe B.R., Bokesch H.R., McMahon J.B., Ratner D.M., Castelli R., Seeberger P.H., Byrd R.A. The Novel Fold of Scytovirin Reveals a New Twist for Antiviral Entry Inhibitors. J. Mol. Biol. 2007;369:451–461. doi: 10.1016/j.jmb.2007.03.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2007.03.030</ArticleId><ArticleId IdType="pmc">PMC2696897</ArticleId><ArticleId IdType="pubmed">17434526</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulaei T., Botos I., Ziółkowska N.E., Bokesch H.R., Krumpe L.R., McKee T.C., O’Keefe B.R., Dauter Z., Wlodawer A. Atomic-Resolution Crystal Structure of the Antiviral Lectin Scytovirin. Protein Sci. 2007;16:2756–2760. doi: 10.1110/ps.073157507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1110/ps.073157507</ArticleId><ArticleId IdType="pmc">PMC2222830</ArticleId><ArticleId IdType="pubmed">17965185</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexandre K.B., Gray E.S., Lambson B.E., Moore P.L., Choge I.A., Mlisana K., Abdool Karim S.S., McMahon J., O’Keefe B., Chikwamba R., et al. Mannose-Rich Glycosylation Patterns on HIV-1 Subtype C Gp120 and Sensitivity to the Lectins, Griffithsin, Cyanovirin-N and Scytovirin. Virology. 2010;402:187–196. doi: 10.1016/j.virol.2010.03.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2010.03.021</ArticleId><ArticleId IdType="pmc">PMC3401642</ArticleId><ArticleId IdType="pubmed">20392471</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Li Q., Wu J., Hu Y., Wu G., Yu C., Xu K., Liu X., Wang Q., Huang W., et al. Lentil Lectin Derived from Lens Culinaris Exhibit Broad Antiviral Activities against SARS-CoV-2 Variants. Emerg. Microbes Infect. 2021;10:1519–1529. doi: 10.1080/22221751.2021.1957720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1957720</ArticleId><ArticleId IdType="pmc">PMC8330776</ArticleId><ArticleId IdType="pubmed">34278967</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahan R.E., Hanifehnezhad A., Kehribar E.Ş., Oguzoglu T.C., Földes K., Özçelik C.E., Filazi N., Öztop S., Palaz F., Önder S., et al. A Highly Potent SARS-CoV-2 Blocking Lectin Protein. ACS Infect. Dis. 2022;8:1253–1264. doi: 10.1021/acsinfecdis.2c00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.2c00006</ArticleId><ArticleId IdType="pmc">PMC9017247</ArticleId><ArticleId IdType="pubmed">35426678</ArticleId></ArticleIdList></Reference><Reference><Citation>Klevanski M., Kim H., Heilemann M., Kuner T., Bartenschlager R. Glycan-Directed SARS-CoV-2 Inhibition by Leek Extract and Lectins with Insights into the Mode-of-Action of Concanavalin A. Antivir. Res. 2024;225:105856. doi: 10.1016/j.antiviral.2024.105856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2024.105856</ArticleId><ArticleId IdType="pubmed">38447646</ArticleId></ArticleIdList></Reference><Reference><Citation>Muñoz-Basagoiti J., Monteiro F.L.L., Krumpe L.R.H., Armario-Najera V., Shenoy S.R., Perez-Zsolt D., Westgarth H.J., Villorbina G., Bomfim L.M., Raïch-Regué D., et al. Cyanovirin-N Binds to Select SARS-CoV-2 Spike Oligosaccharides Outside of the Receptor Binding Domain and Blocks Infection by SARS-CoV-2. Proc. Natl. Acad. Sci. USA. 2023;120:e2214561120. doi: 10.1073/pnas.2214561120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2214561120</ArticleId><ArticleId IdType="pmc">PMC10013841</ArticleId><ArticleId IdType="pubmed">36853940</ArticleId></ArticleIdList></Reference><Reference><Citation>Crispin M., Ward A.B., Wilson I.A. Structure and Immune Recognition of the HIV Glycan Shield. Annu. Rev. Biophys. 2018;47:499–523. doi: 10.1146/annurev-biophys-060414-034156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biophys-060414-034156</ArticleId><ArticleId IdType="pmc">PMC6163090</ArticleId><ArticleId IdType="pubmed">29595997</ArticleId></ArticleIdList></Reference><Reference><Citation>Pritchard L.K., Spencer D.I.R., Royle L., Bonomelli C., Seabright G.E., Behrens A.-J., Kulp D.W., Menis S., Krumm S.A., Dunlop D.C., et al. Glycan Clustering Stabilizes the Mannose Patch of HIV-1 and Preserves Vulnerability to Broadly Neutralizing Antibodies. Nat. Commun. 2015;6:7479. doi: 10.1038/ncomms8479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8479</ArticleId><ArticleId IdType="pmc">PMC4500839</ArticleId><ArticleId IdType="pubmed">26105115</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls A.C., Tortorici M.A., Frenz B., Snijder J., Li W., Rey F.A., DiMaio F., Bosch B.-J., Veesler D. Glycan Shield and Epitope Masking of a Coronavirus Spike Protein Observed by Cryo-Electron Microscopy. Nat. Struct. Mol. Biol. 2016;23:899–905. doi: 10.1038/nsmb.3293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.3293</ArticleId><ArticleId IdType="pmc">PMC5515730</ArticleId><ArticleId IdType="pubmed">27617430</ArticleId></ArticleIdList></Reference><Reference><Citation>Koharudin L.M.I., Gronenborn A.M. Antiviral Lectins as Potential HIV Microbicides. Curr. Opin. Virol. 2014;7:95–100. doi: 10.1016/j.coviro.2014.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2014.05.006</ArticleId><ArticleId IdType="pmc">PMC4149946</ArticleId><ArticleId IdType="pubmed">25010042</ArticleId></ArticleIdList></Reference><Reference><Citation>Huskens D., Schols D. Algal Lectins as Potential HIV Microbicide Candidates. Mar. Drugs. 2012;10:1476–1497. doi: 10.3390/md10071476.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/md10071476</ArticleId><ArticleId IdType="pmc">PMC3407925</ArticleId><ArticleId IdType="pubmed">22851920</ArticleId></ArticleIdList></Reference><Reference><Citation>Altıntaş Ö., Saylan Y. Exploring the Versatility of Exosomes: A Review on Isolation, Characterization, Detection Methods, and Diverse Applications. Anal. Chem. 2023;95:16029–16048. doi: 10.1021/acs.analchem.3c02224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.3c02224</ArticleId><ArticleId IdType="pubmed">37874907</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalluri R., LeBleu V.S. The Biology, Function, and Biomedical Applications of Exosomes. Science. 2020;367:eaau6977. doi: 10.1126/science.aau6977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aau6977</ArticleId><ArticleId IdType="pmc">PMC7717626</ArticleId><ArticleId IdType="pubmed">32029601</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y., Kim Y., Ha S., Sheller-Miller S., Yoo J., Choi C., Park C.H. The Emerging Role of Exosomes as Novel Therapeutics: Biology, Technologies, Clinical Applications, and the Next. Am. J. Reprod. Immunol. 2021;85:e13329. doi: 10.1111/aji.13329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aji.13329</ArticleId><ArticleId IdType="pmc">PMC7900947</ArticleId><ArticleId IdType="pubmed">32846024</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutai E., Ngu A.K.H., Zempleni J. Preliminary Evidence That Lectins in Infant Soy Formula Apparently Bind Bovine Milk Exosomes and Prevent Their Absorption in Healthy Adults. BMC Nutr. 2022;8:7. doi: 10.1186/s40795-022-00503-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40795-022-00503-0</ArticleId><ArticleId IdType="pmc">PMC8780320</ArticleId><ArticleId IdType="pubmed">35063038</ArticleId></ArticleIdList></Reference><Reference><Citation>Muthu S., Bapat A., Jain R., Jeyaraman N., Jeyaraman M. Exosomal Therapy—A New Frontier in Regenerative Medicine. Stem Cell Investig. 2021;8:7. doi: 10.21037/sci-2020-037.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/sci-2020-037</ArticleId><ArticleId IdType="pmc">PMC8100822</ArticleId><ArticleId IdType="pubmed">33969112</ArticleId></ArticleIdList></Reference><Reference><Citation>Gajos-Michniewicz A., Duechler M., Czyz M. MiRNA in Melanoma-Derived Exosomes. Cancer Lett. 2014;347:29–37. doi: 10.1016/j.canlet.2014.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2014.02.004</ArticleId><ArticleId IdType="pubmed">24513178</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Ren L., Li S., Li W., Zheng X., Yang Y., Fu W., Yi J., Wang J., Du G. The Biology, Function, and Applications of Exosomes in Cancer. Acta Pharm. Sin. B. 2021;11:2783–2797. doi: 10.1016/j.apsb.2021.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2021.01.001</ArticleId><ArticleId IdType="pmc">PMC8463268</ArticleId><ArticleId IdType="pubmed">34589397</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Yan Z., Yuan Y., Xing C., Jiang N. The Role of Exosomes in Viral Hepatitis and Its Associated Liver Diseases. Front. Med. 2021;8:782485. doi: 10.3389/fmed.2021.782485.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.782485</ArticleId><ArticleId IdType="pmc">PMC8645545</ArticleId><ArticleId IdType="pubmed">34881274</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B., Lu Y., Chen X., Muthuraj P.G., Li X., Pattabiraman M., Zempleni J., Kachman S.D., Natarajan S.K., Yu J. Protective Role of Shiitake Mushroom-Derived Exosome-Like Nanoparticles in D-Galactosamine and Lipopolysaccharide-Induced Acute Liver Injury in Mice. Nutrients. 2020;12:477. doi: 10.3390/nu12020477.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12020477</ArticleId><ArticleId IdType="pmc">PMC7071144</ArticleId><ArticleId IdType="pubmed">32069862</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.-X., Cai Q. Plant Exosome-like Nanovesicles and Their Role in the Innovative Delivery of RNA Therapeutics. Biomedicines. 2023;11:1806. doi: 10.3390/biomedicines11071806.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11071806</ArticleId><ArticleId IdType="pmc">PMC10376343</ArticleId><ArticleId IdType="pubmed">37509446</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Zhou Y., Yu J. Exosome-like Nanoparticles from Ginger Rhizomes Inhibited NLRP3 Inflammasome Activation. Mol. Pharm. 2019;16:2690–2699. doi: 10.1021/acs.molpharmaceut.9b00246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.molpharmaceut.9b00246</ArticleId><ArticleId IdType="pubmed">31038962</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B., Li X., Yu H., Shi X., Zhou Y., Alvarez S., Naldrett M.J., Kachman S.D., Ro S.-H., Sun X., et al. Therapeutic Potential of Garlic Chive-Derived Vesicle-like Nanoparticles in NLRP3 Inflammasome-Mediated Inflammatory Diseases. Theranostics. 2021;11:9311–9330. doi: 10.7150/thno.60265.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.60265</ArticleId><ArticleId IdType="pmc">PMC8490522</ArticleId><ArticleId IdType="pubmed">34646372</ArticleId></ArticleIdList></Reference><Reference><Citation>Millet J.K., Tang T., Nathan L., Jaimes J.A., Hsu H.-L., Daniel S., Whittaker G.R. Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting. J. Vis. Exp. 2019;145:e59010. doi: 10.3791/59010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/59010</ArticleId><ArticleId IdType="pmc">PMC6677141</ArticleId><ArticleId IdType="pubmed">30882796</ArticleId></ArticleIdList></Reference><Reference><Citation>Conforti A., Marra E., Palombo F., Roscilli G., Ravà M., Fumagalli V., Muzi A., Maffei M., Luberto L., Lione L., et al. COVID-eVax, an Electroporated DNA Vaccine Candidate Encoding the SARS-CoV-2 RBD, Elicits Protective Responses in Animal Models. Mol. Ther. 2022;30:311–326. doi: 10.1016/j.ymthe.2021.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2021.09.011</ArticleId><ArticleId IdType="pmc">PMC8483992</ArticleId><ArticleId IdType="pubmed">34547465</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho H., Gonzales-Wartz K.K., Huang D., Yuan M., Peterson M., Liang J., Beutler N., Torres J.L., Cong Y., Postnikova E., et al. Bispecific Antibodies Targeting Distinct Regions of the Spike Protein Potently Neutralize SARS-CoV-2 Variants of Concern. Sci. Transl. Med. 2021;13:eabj5413. doi: 10.1126/scitranslmed.abj5413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abj5413</ArticleId><ArticleId IdType="pmc">PMC8651051</ArticleId><ArticleId IdType="pubmed">34519517</ArticleId></ArticleIdList></Reference><Reference><Citation>Dacon C., Tucker C., Peng L., Lee C.-C.D., Lin T.-H., Yuan M., Cong Y., Wang L., Purser L., Williams J.K., et al. Broadly Neutralizing Antibodies Target the Coronavirus Fusion Peptide. Science. 2022;377:728–735. doi: 10.1126/science.abq3773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abq3773</ArticleId><ArticleId IdType="pmc">PMC9348754</ArticleId><ArticleId IdType="pubmed">35857439</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiggins J., Nguyen N., Wei W., Wang L.L., Hollingsead Olson H., Xiang S.-H. Lactic Acid Bacterial Surface Display of Scytovirin Inhibitors for Anti-Ebolavirus Infection. Front. Microbiol. 2023;14:1269869. doi: 10.3389/fmicb.2023.1269869.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2023.1269869</ArticleId><ArticleId IdType="pmc">PMC10704896</ArticleId><ArticleId IdType="pubmed">38075878</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Deng W., Klinke D.J. Exosomes: Improved Methods to Characterize Their Morphology, RNA Content, and Surface Protein Biomarkers. Analyst. 2015;140:6631–6642. doi: 10.1039/C5AN00688K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C5AN00688K</ArticleId><ArticleId IdType="pmc">PMC4986832</ArticleId><ArticleId IdType="pubmed">26332016</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto Z., Jackson A., Michikawa M., Maehara T., Momma M., Henrissat B., Gilbert H.J., Kaneko S. The Structure of a Streptomyces Avermitilis α-l-Rhamnosidase Reveals a Novel Carbohydrate-Binding Module CBM67 within the Six-Domain Arrangement. J. Biol. Chem. 2013;288:12376–12385. doi: 10.1074/jbc.M113.460097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.460097</ArticleId><ArticleId IdType="pmc">PMC3636921</ArticleId><ArticleId IdType="pubmed">23486481</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb B., Sali A. Comparative Protein Structure Modeling Using MODELLER. Curr. Protoc. Bioinform. 2016;54:5.6.1–5.6.37. doi: 10.1002/cpbi.3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpbi.3</ArticleId><ArticleId IdType="pmc">PMC5031415</ArticleId><ArticleId IdType="pubmed">27322406</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley L.A., Mezulis S., Yates C.M., Wass M.N., Sternberg M.J.E. The Phyre2 Web Portal for Protein Modeling, Prediction and Analysis. Nat. Protoc. 2015;10:845–858. doi: 10.1038/nprot.2015.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2015.053</ArticleId><ArticleId IdType="pmc">PMC5298202</ArticleId><ArticleId IdType="pubmed">25950237</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu D., Bowder D., Wei W., Thompson J., Wilson M.A., Xiang S.-H. Tryptophan 375 Stabilizes the Outer-Domain Core of Gp120 for HIV Vaccine Immunogen Design. Vaccine. 2017;35:3067–3075. doi: 10.1016/j.vaccine.2017.04.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.04.054</ArticleId><ArticleId IdType="pmc">PMC5440730</ArticleId><ArticleId IdType="pubmed">28461065</ArticleId></ArticleIdList></Reference><Reference><Citation>Vajravijayan S., Pletnev S., Luo Z., Pletnev V.Z., Nandhagopal N., Gunasekaran K. Crystallographic and Calorimetric Analysis on Pleurotus Ostreatus Lectin and Its Sugar Complexes—Promiscuous Binding Driven by Geometry. Int. J. Biol. Macromol. 2020;152:862–872. doi: 10.1016/j.ijbiomac.2020.02.294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2020.02.294</ArticleId><ArticleId IdType="pubmed">32112837</ArticleId></ArticleIdList></Reference><Reference><Citation>Perduca M., Destefanis L., Bovi M., Galliano M., Munari F., Assfalg M., Ferrari F., Monaco H.L., Capaldi S. Structure and Properties of the Oyster Mushroom (Pleurotus ostreatus) Lectin. Glycobiology. 2020;30:550–562. doi: 10.1093/glycob/cwaa006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/cwaa006</ArticleId><ArticleId IdType="pubmed">31985778</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Gao J., Ng T.B. A New Lectin with Highly Potent Antihepatoma and Antisarcoma Activities from the Oyster Mushroom Pleurotus Ostreatus. Biochip. Biophys. Res. Commun. 2000;275:810–816. doi: 10.1006/bbrc.2000.3373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.2000.3373</ArticleId><ArticleId IdType="pubmed">10973803</ArticleId></ArticleIdList></Reference><Reference><Citation>Shajahan A., Pepi L.E., Kumar B., Murray N.B., Azadi P. Site Specific N- and O-Glycosylation Mapping of the Spike Proteins of SARS-CoV-2 Variants of Concern. Sci. Rep. 2023;13:10053. doi: 10.1038/s41598-023-33088-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-33088-0</ArticleId><ArticleId IdType="pmc">PMC10284906</ArticleId><ArticleId IdType="pubmed">37344512</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes C.D.G., Onigbinde S., Sanni A., Bennett A.I., Jiang P., Daramola O., Ahmadi P., Fowowe M., Atashi M., Sandilya V., et al. N-Glycome Profile of the Spike Protein S1: Systemic and Comparative Analysis from Eleven Variants of SARS-CoV-2. Biomolecules. 2023;13:1421. doi: 10.3390/biom13091421.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom13091421</ArticleId><ArticleId IdType="pmc">PMC10526240</ArticleId><ArticleId IdType="pubmed">37759821</ArticleId></ArticleIdList></Reference><Reference><Citation>Aloor A., Aradhya R., Venugopal P., Gopalakrishnan Nair B., Suravajhala R. Glycosylation in SARS-CoV-2 Variants: A Path to Infection and Recovery. Biochem. Pharmacol. 2022;206:115335. doi: 10.1016/j.bcp.2022.115335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2022.115335</ArticleId><ArticleId IdType="pmc">PMC9621623</ArticleId><ArticleId IdType="pubmed">36328134</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng R., Wu L.-A., Wang Q., Qi J., Gao G.F. Cell Entry by SARS-CoV-2. Trends Biochem. Sci. 2021;46:848–860. doi: 10.1016/j.tibs.2021.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2021.06.001</ArticleId><ArticleId IdType="pmc">PMC8180548</ArticleId><ArticleId IdType="pubmed">34187722</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C.B., Farzan M., Chen B., Choe H. Mechanisms of SARS-CoV-2 Entry into Cells. Nat. Rev. Mol. Cell Biol. 2022;23:3–20. doi: 10.1038/s41580-021-00418-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng B., Abdullahi A., Ferreira I.A.T.M., Goonawardane N., Saito A., Kimura I., Yamasoba D., Gerber P.P., Fatihi S., Rathore S., et al. Altered TMPRSS2 Usage by SARS-CoV-2 Omicron Impacts Infectivity and Fusogenicity. Nature. 2022;603:706–714. doi: 10.1038/s41586-022-04474-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04474-x</ArticleId><ArticleId IdType="pmc">PMC8942856</ArticleId><ArticleId IdType="pubmed">35104837</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakurai Y., Okada S., Ozeki T., Yoshikawa R., Kinoshita T., Yasuda J. SARS-CoV-2 Omicron Subvariants Progressively Adapt to Human Cells with Altered Host Cell Entry. mSphere. 2024;9:e0033824. doi: 10.1128/msphere.00338-24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/msphere.00338-24</ArticleId><ArticleId IdType="pmc">PMC11423564</ArticleId><ArticleId IdType="pubmed">39191389</ArticleId></ArticleIdList></Reference><Reference><Citation>Pires De Souza G.A., Le Bideau M., Boschi C., Wurtz N., Colson P., Aherfi S., Devaux C., La Scola B. Choosing a Cellular Model to Study SARS-CoV-2. Front. Cell. Infect. Microbiol. 2022;12:1003608. doi: 10.3389/fcimb.2022.1003608.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.1003608</ArticleId><ArticleId IdType="pmc">PMC9634005</ArticleId><ArticleId IdType="pubmed">36339347</ArticleId></ArticleIdList></Reference><Reference><Citation>Eghianruwa Q., Odekanyin O., Kuku A. Physicochemical Properties and Acute Toxicity Studies of a Lectin from the Saline Extract of the Fruiting Bodies of the Shiitake Mushroom, Lentinula Edodes (Berk) Int. J. Biochem. Mol. Biol. 2011;2:309–317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3242429</ArticleId><ArticleId IdType="pubmed">22187665</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Chen S., Liu Q. Lectin from the Late Oyster Mushroom, Hohenbuehelia Serotina (Agaricomycetes), and Its Novel Effect as an Adjuvant of the HBV DNA Vaccine. Int. J. Med. Mushrooms. 2017;19:1123–1133. doi: 10.1615/IntJMedMushrooms.2017024762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1615/IntJMedMushrooms.2017024762</ArticleId><ArticleId IdType="pubmed">29431073</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>